Gery Florek
Neurology · Tallahassee, FLNPI 1205919677
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $56,765 of the $66,885 with a category attached, or 84.9%. 33 manufacturers reported payments, led by AbbVie at 42.1% of the total. Reporting peaked in 2021 at $36,602 and has fallen 99.8% since, to $70 in 2024. Among neurology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 554 payments — averaging $120.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$28K
- Lilly USA, LLC$23K
- Amgen$7K
- Biohaven Pharmaceuticals, Inc.$4K
- Biogen$626
- Novartis$500
- plus $4K from 27 others
What the payments were for
- Speaking & faculty fees$56,76585%
- Grants$420%
- Travel & lodging$1,5542%
- Food & beverage$8,43513%
- Education$900%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 96 | $28,149 |
| Lilly USA, LLC | 94 | $22,545 |
| Amgen | 48 | $6,509 |
| Biohaven Pharmaceuticals, Inc. | 9 | $4,471 |
| Biogen | 44 | $626 |
| Novartis | 30 | $500 |
| Adamas Pharmaceuticals, Inc. | 27 | $463 |
| Supernus Pharmaceuticals, Inc. | 44 | $447 |
| Upsher-smith Laboratories LLC | 23 | $379 |
| Teva Pharmaceuticals USA, Inc. | 28 | $373 |
| Lundbeck LLC | 13 | $360 |
| Eisai Inc. | 14 | $263 |
| Amneal Pharmaceuticals LLC | 14 | $221 |
| UCB, Inc. | 10 | $199 |
| Jazz Pharmaceuticals Inc. | 2 | $166 |
| Assertio Therapeutics, Inc. | 6 | $120 |
| EMD Serono, Inc. | 8 | $117 |
| Arbor Pharmaceuticals, Inc. | 8 | $114 |
| E.r. Squibb & Sons, L.L.C. | 1 | $112 |
| SK Life Science, Inc. | 6 | $110 |
| AstraZeneca | 1 | $106 |
| Avanir Pharmaceuticals, Inc. | 4 | $76 |
| Novocure Inc. | 2 | $74 |
| Sanofi | 4 | $72 |
| Zyla Life Sciences, Inc. | 4 | $58 |
| Acadia Pharmaceuticals Inc | 3 | $57 |
| Neurocrine Biosciences, Inc. | 3 | $48 |
| Greenwich Biosciences, Inc. | 2 | $47 |
| Promius Pharma LLC | 2 | $35 |
| Tanabe Pharma America, Inc. | 1 | $22 |
| Bristol Myers Squibb | 1 | $20 |
| Genentech USA, Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$66,885 in reported general payments places this provider in the 90th percentile of 1,434 neurology providers in Florida.
Other neurology in Tallahassee
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
- Donald NegroskiSarasota$1.4M
- Mark CascioneTampa$1.2M
- Lance KimOcala$1M
- Tuan VuTampa$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.